MedAvail Holdings, Inc. Common Stock
MDVL
MDVL was delisted on the 12th of February, 2024.
32 hedge funds and large institutions have $53.9M invested in MedAvail Holdings, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 11 closing their positions.
45,700% more call options, than puts
Call options by funds: $458K | Put options by funds: $1K
0.78% more ownership
Funds ownership: 86.01% → 86.79% (+0.78%)
16% less funds holding
Funds holding: 38 → 32 (-6)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
42% less capital invested
Capital invested by funds: $92.8M → $53.9M (-$39M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$10.8M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$50.6K |
| 3 |
Renaissance Technologies
New York
|
+$45.7K |
| 4 |
Man Group
London,
United Kingdom
|
+$36.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$25.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$528K |
| 2 |
Millennium Management
New York
|
-$97.6K |
| 3 |
Belvedere Trading
Chicago,
Illinois
|
-$74K |
| 4 |
Morgan Stanley
New York
|
-$64.4K |
| 5 |
VF
Virtu Financial
New York
|
-$42K |
MDVL Hedge Fund Activity: Q3 2022 in Review
32 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q3 2022, worth a combined $53.9M — down 42% from $92.8M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of MDVL and 5 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was Redmile Group, adding an estimated $10.8M. The largest seller was Alyeska Investment Group, cutting an estimated $528K.
- 32 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q3 2022, down from 38 in Q2 2022.
- Funds reported $53.9M of MedAvail Holdings, Inc. Common Stock stock for Q3 2022, down 42% quarter-over-quarter.
- 5 funds opened new MedAvail Holdings, Inc. Common Stock positions in Q3 2022 and 11 closed out, a net change of -6 holders.
- The largest MedAvail Holdings, Inc. Common Stock buyer in Q3 2022 was Redmile Group, an estimated $10.8M added.
- The largest MedAvail Holdings, Inc. Common Stock seller in Q3 2022 was Alyeska Investment Group, an estimated $528K sold.
Based on aggregated 13F filings for Q3 2022.